Quantcast

Latest Hydromorphone Stories

2009-06-17 06:00:00

CONSHOHOCKEN, PA and VANCOUVER, BC, June 17 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that its subsidiary Neuromed Development Inc., has sold the U.S. rights to its lead investigational drug candidate, Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII), to Covidien's subsidiary Mallinckrodt Inc. On March 23, 2009, Neuromed announced that Exalgo met the primary endpoint in a pivotal phase III clinical trial. On May 22, 2009, Neuromed submitted a response to an...

2009-06-16 15:05:00

CUPERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Joseph Stauffer has joined DURECT as Chief Medical Officer and Executive Vice President, Corporate Strategy. (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) "Dr. Stauffer's successful leadership of clinical research and medical affairs for pain products while at Alpharma and Abbott, and first-hand experience with the regulatory approval process gained during his...

2009-06-11 08:00:00

CONSHOHOCKEN, PA and VANCOUVER, BC, June 11 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that it has received notification that Merck & Co., Inc. will terminate the research collaboration and license agreement for novel compounds targeting N-type calcium channels for the treatment of pain and other disorders, which the companies entered into in March of 2006. "Over the past three years we have had an excellent and extremely productive collaboration with our colleagues at...

2009-06-10 00:21:03

A coroner in Las Vegas has ruled impressionist Danny Gans died accidentally of heart failure brought on by a toxic level of the pain killer hydromorphone. Clark County Coroner Mike Murphy would not characterize the May 1 death of the 52-year-old performer as a drug overdose, The New York Times reported Thursday. He also did not disclose the level of hydromorphone, which is marketed as Dilaudid, in Gans's system. Chip Lightman, Gans's manager, said he didn't know his client was using the...

2009-05-29 08:26:00

- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of Oxycodone MELBOURNE, Australia, May 29 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system. The results of the preclinical studies demonstrated that by incorporating TPM/oxycodone into innovative patch...

2009-05-26 14:24:00

BETHESDA, Md., May 26 /PRNewswire/ -- On May 27 and 28, 2009, the Food and Drug Administration (FDA) will hear testimony about the FDA-guided effort to develop a classwide Risk Evaluation and Mitigation Strategy (REMS) for all controlled-release opioids from more than 70 patients, scientists, public health professionals, and representatives of pharmacist groups, prescriber groups, and pharmaceutical companies. Controlled-release opioids include prescription pain medications that release the...

d21e7fc30592931ebdbfffd069d9ea3c1
2009-04-10 16:22:05

Oh Thursday, the Food and Drug Administration reversed its initial plan to remove unapproved liquid morphine from being sold in the US. On March 30, the FDA decided to disallow the marketing of 14 medications, including morphine elixir, which has long been used to relieve pain in patients that are near-death. Nine companies were informed not to market the 14 unapproved narcotic pain medicines within 60 days of notification. Seven of those companies make or distribute the liquid morphine,...

70885b368069d92ac375d85b779f91c0
2009-04-01 07:50:00

The Food and Drug Administration told nine manufacturers to quit distributing 14 unapproved narcotic painkillers drugs within 90 days. Yet, federal regulators insisted there are numerous legal versions of the painkillers for patients who need relief. "There will be no shortage for consumers," said Deborah Autor, director of FDA's drug compliance office. The government ordered unapproved prescription versions of potent morphine, hydromorphone, and oxycodone off the market. The FDA estimates...

2009-03-31 10:36:02

The U.S. Food and Drug Administration is warning nine companies to stop manufacturing 14 unapproved narcotic drugs that are widely used to treat pain. The FDA's warning letters notified the companies they may be subject to enforcement action if they don't stop manufacturing and distributing unapproved prescription drugs containing high concentrations of morphine sulfate, hydromorphone or oxycodone. The action does not include oxycodone capsules, officials said. Consumers have a right to...

2009-03-23 07:00:00

CONSHOHOCKEN, PA and VANCOUVER, BC, March 23 /PRNewswire/ - Neuromed Pharmaceuticals, Inc. today announced positive results of a pivotal phase 3 clinical trial of its lead investigational drug, Exalgo (hydromorphone HCl) Extended-Release Tablets (CII) (previously NMED-1077 and OROS(R) Hydromorphone). The trial met its primary efficacy endpoint, the mean change from baseline to week 12 (or last visit) of average weekly pain intensity scores, and the results were statistically significant...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related